Gilead shareholders crush plan to tie CEO compensation to drug access

Gilead Sciences Inc. shareholders thumped a proposal Wednesday that would have tied the compensation of CEO John Martin to patient access to the company's groundbreaking drugs...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.